Alliance Pharma's market cap is currently £327.58M. The company's EPS TTM is p-0.062; its P/E ratio is ―; Alliance Pharma is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is p2.50. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 180.68M	£ 167.42M	£ 163.21M	£ 129.80M	£ 135.64M
Gross Profit	£ 105.02M	£ 101.68M	£ 109.45M	£ 82.82M	£ 86.08M
Operating Income	£ -38.44M	£ 10.57M	£ 21.57M	£ 27.15M	£ 35.63M
EBITDA	£ -28.94M	£ -6.86M	£ 31.91M	£ 24.58M	£ 36.53M
Net Income	£ -33.14M	£ 936.00K	£ 7.32M	£ 8.03M	£ 25.01M
Balance Sheet
Cash & Short-Term Investments	£ 22.44M	£ 31.71M	£ 29.06M	£ 28.90M	£ 17.83M
Total Assets	£ 414.92M	£ 537.41M	£ 503.49M	£ 508.85M	£ 407.64M
Total Debt	£ 117.42M	£ 133.74M	£ 116.06M	£ 142.02M	£ 80.06M
Net Debt	£ 94.98M	£ 102.03M	£ 87.00M	£ 113.13M	£ 62.23M
Total Liabilities	£ 197.05M	£ 249.75M	£ 221.00M	£ 227.90M	£ 133.46M
Stockholders' Equity	£ 217.87M	£ 287.66M	£ 282.49M	£ 280.96M	£ 274.18M
Cash Flow
Free Cash Flow	£ 30.71M	£ 20.36M	£ 33.13M	£ 36.95M	£ 31.60M
Operating Cash Flow	£ 31.41M	£ 20.97M	£ 38.66M	£ 41.57M	£ 35.76M
Investing Cash Flow	£ -918.00K	£ -17.02M	£ -4.60M	£ -85.86M	£ -3.28M
Financing Cash Flow	£ -39.19M	£ -876.00K	£ -34.34M	£ 55.75M	£ -25.20M

Currency in GBP

Alliance Pharma Earnings and Revenue History

Income Statement >

Alliance Pharma Debt to Assets

Balance Sheet >

Alliance Pharma Cash Flow

Cash Flow >

Alliance Pharma Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing